Concepedia

First-in-human phase I trial of the anti-CEACAM5 antibody–drug conjugate SAR408701 in patients with advanced solid tumors (NCT02187848)

A. Gazzah, Neda Stjepanovic, Min‐Hee Ryu, Josep Tabernero, J.C. Soria, P. Bedard, Yan Kang, R. Bahleda, Hélène Guillemin‐Paveau, Christophe Henry,

European Journal of Cancer · 2016 · 10 citations · 0 references

DOI

Concepts